The analysis revealed that TAGLN2 expression in normal breast, stomach, skin, kidney (Figure 2H), cervix, colon, endometrium, nasopharynx, liver, lung, ovary, pancreas, and urinary bladder (Figure S1B) tissues were weak or negative, whereas in the corresponding tumor tissues, such expressions were moderate or strong. This evidence concerns the gene TAGLN2 and neoplasm.